These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29319276)

  • 1. Pathways in melanoma development.
    Erlich TH; Fisher DE
    G Ital Dermatol Venereol; 2018 Feb; 153(1):68-76. PubMed ID: 29319276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging targeted therapies for melanoma.
    Johnson DB; Pollack MH; Sosman JA
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):195-207. PubMed ID: 27148822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the management of melanoma: targeted therapy, immunotherapy and future directions.
    Dean E; Lorigan P
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1437-48. PubMed ID: 23249108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.
    Xu DH; Zhu Z; Xiao H; Wakefield MR; Bai Q; Nicholl MB; Ding VA; Fang Y
    Cancer Lett; 2017 May; 394():43-51. PubMed ID: 28254411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma: understanding relevant molecular pathways as well as available and emerging therapies.
    McKibbin T
    Am J Manag Care; 2015 Sep; 21(10 Suppl):S224-33. PubMed ID: 26619296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards new therapeutic approaches for malignant melanoma.
    Pacheco I; Buzea C; Tron V
    Expert Rev Mol Med; 2011 Nov; 13():e33. PubMed ID: 22044938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Melanoma and search for therapeutic targets].
    de la Fouchardière A
    Ann Pathol; 2011 Nov; 31(5 Suppl):S123-4. PubMed ID: 22054449
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of novel therapies for melanoma.
    Karimkhani C; Gonzalez R; Dellavalle RP
    Am J Clin Dermatol; 2014 Aug; 15(4):323-37. PubMed ID: 24928310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging clinical issues in melanoma in the molecularly targeted era.
    Sullivan RJ; Atkins MB
    Methods Mol Biol; 2014; 1102():11-26. PubMed ID: 24258971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New therapeutic options in the medical management of advanced melanoma.
    Lutzky J
    Semin Cutan Med Surg; 2010 Dec; 29(4):249-57. PubMed ID: 21277538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenetics of melanoma: basis for molecular diagnostics and therapy.
    Held L; Eigentler TK; Meier F; Held M; Röcken M; Garbe C; Bauer J
    J Dtsch Dermatol Ges; 2011 Jul; 9(7):510-6. PubMed ID: 21244632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutical strategies in the treatment of metastatic disease.
    Julia F; Thomas L; Dalle S
    Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bench to bedside: mechanistic principles of targeting the RAF kinase in melanoma.
    Rajakulendran T; Adam DN
    Int J Dermatol; 2014 Dec; 53(12):1428-33. PubMed ID: 25311997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The melanoma revolution: from UV carcinogenesis to a new era in therapeutics.
    Lo JA; Fisher DE
    Science; 2014 Nov; 346(6212):945-9. PubMed ID: 25414302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drug targets in metastatic melanoma.
    Homet B; Ribas A
    J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Side effects and toxicities of targeted therapies in stage IV melanoma.
    Ascierto PA; Bastholt L; Hersey P; Cinat G; Eggermont AM; Hauschild A; Espinosa E; Robert C
    Am J Ther; 2015; 22(1):44-53. PubMed ID: 24185314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving patient outcomes to targeted therapies in melanoma.
    Eroglu Z; Smalley KS; Sondak VK
    Expert Rev Anticancer Ther; 2016 Jun; 16(6):633-41. PubMed ID: 27137746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational modeling in melanoma for novel drug discovery.
    Pennisi M; Russo G; Di Salvatore V; Candido S; Libra M; Pappalardo F
    Expert Opin Drug Discov; 2016 Jun; 11(6):609-21. PubMed ID: 27046143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successes and limitations of targeted cancer therapy in melanoma.
    Romano E; Michielin O
    Prog Tumor Res; 2014; 41():78-88. PubMed ID: 24727988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma.
    Kim A; Cohen MS
    Expert Opin Drug Discov; 2016 Sep; 11(9):907-16. PubMed ID: 27327499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.